Broad Institute licenses CRISPR/Cas9 tech to Transposagen
Transposagen, a Kentucky biotech that develops research tools and animal models for drug discovery, will add CRISPR technology to its existing suite of gene editing tools.
Charles River Laboratories, Transposagen Biopharmaceuticals sign deal for lab rats
Transposagen Biopharmaceuticals Inc. signed an exclusive licensing deal with Charles River Laboratories International Inc. (NYSE:CRL) for lab rats. Under the agreement, Wilmington, Mass.-based Charles River will market and distribute the Lexington, Ky.-based lab rat developer’s p53 and Bcrp TGEM Knockout rat models, so named for mutations in their p53 and Bcrp genes. The rats mimic […]
The Mechanics of a More Connected Healthcare Ecosystem [Video]
Arbiter’s Anjali Jameson on hospital and payer alignment.